vimarsana.com

Page 36 - Dexcom Real Time News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New York State Teachers Retirement System Sells 16,064 Shares of DexCom, Inc (NASDAQ:DXCM)

New York State Teachers Retirement System Sells 16,064 Shares of DexCom, Inc (NASDAQ:DXCM)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Brokerages Set DexCom, Inc (NASDAQ:DXCM) Price Target at $131 94

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the fifteen ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has assigned a strong buy […]

Analysts Set DexCom, Inc (NASDAQ:DXCM) Target Price at $131 94

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fifteen brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the […]

DexCom, Inc (NASDAQ:DXCM) Shares Sold by Brown Advisory Inc

Brown Advisory Inc. decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 27.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,690,930 shares of the medical device company’s stock after selling 639,303 shares during the quarter. Brown Advisory […]

DexCom (NASDAQ:DXCM) Given New $147 00 Price Target at Raymond James

DexCom (NASDAQ:DXCM – Get Free Report) had its price target lifted by stock analysts at Raymond James from $131.00 to $147.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ target price suggests a potential upside of 22.45% from the company’s […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.